Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M104,497Revenue $M35,551Net Margin (%)2.5Altman Z-Score1.3
Enterprise Value $M128,015EPS $0.4Operating Margin %7.5Piotroski F-Score4
P/E(ttm)112Beneish M-Score-2.6Pre-tax Margin (%)4.7Higher ROA y-yN
Price/Book25.310-y EBITDA Growth Rate %1.7Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %7.4Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow131y-y EBITDA Growth Rate %-73.8ROA % (ttm)1.1Higher Current Ratio y-yN
Dividend Yield %5.5PEG15.2ROE % (ttm)11.1Less Shares Outstanding y-yN
Payout Ratio %635Shares Outstanding M2,435ROIC % (ttm)7.7Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKKen Fisher 2016-03-31 Add0.01%$38.54 - $42.05
($39.84)
$ 42.918%Add 1.09%11,657,855
GSKCharles Brandes 2015-12-31 Reduce-0.21%$39.1 - $43.53
($40.81)
$ 42.915%Reduce -7.92%4,303,030
GSKKahn Brothers 2015-12-31 Add0.2%$39.1 - $43.53
($40.81)
$ 42.915%Add 47.13%84,600
GSKHOTCHKIS & WILEY 2015-12-31 Reduce-0.05%$39.1 - $43.53
($40.81)
$ 42.915%Reduce -2.40%12,102,919
GSKJohn Rogers 2015-12-31 Add0.01%$39.1 - $43.53
($40.81)
$ 42.915%Add 1.29%1,476,976
GSKKen Fisher 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 42.915%Add 0.03%11,531,673
GSKTweedy Browne 2015-12-31 Reduce$39.1 - $43.53
($40.81)
$ 42.915%Reduce -0.25%133,124
GSKNWQ Managers 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 42.915%Add 1.68%469,830
GSKDodge & Cox 2015-12-31 Reduce$39.1 - $43.53
($40.81)
$ 42.915%Reduce -44.42%112,782
GSKJoel Greenblatt 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 42.915%Add 1.01%51,973
GSKDodge & Cox 2015-09-30 Reduce-0.46%$37.56 - $45.14
($41.64)
$ 42.913%Reduce -98.37%202,915
GSKCharles Brandes 2015-09-30 Add0.2%$37.56 - $45.14
($41.64)
$ 42.913%Add 8.33%4,673,082
GSKJohn Rogers 2015-09-30 Add0.12%$37.56 - $45.14
($41.64)
$ 42.913%Add 20.07%1,458,162
GSKHOTCHKIS & WILEY 2015-09-30 Add0.12%$37.56 - $45.14
($41.64)
$ 42.913%Add 6.76%12,400,884
GSKNWQ Managers 2015-09-30 Reduce-0.03%$37.56 - $45.14
($41.64)
$ 42.913%Reduce -9.49%462,055
GSKJoel Greenblatt 2015-09-30 Reduce-0.01%$37.56 - $45.14
($41.64)
$ 42.913%Reduce -35.81%51,451
GSKTweedy Browne 2015-09-30 Add0.01%$37.56 - $45.14
($41.64)
$ 42.913%Add 4.03%133,458
GSKKahn Brothers 2015-09-30 Reduce$37.56 - $45.14
($41.64)
$ 42.913%Reduce -1.20%57,500
GSKBarrow, Hanley, Mewhinney & Strauss 2015-09-30 Reduce$37.56 - $45.14
($41.64)
$ 42.913%Reduce -1.31%249,000
GSKKen Fisher 2015-09-30 Reduce$37.56 - $45.14
($41.64)
$ 42.913%Reduce -0.05%11,528,069
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2295.05view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14102.98view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29711.15view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12257.58view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14206.5view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12257.58view

Press Releases about GSK :

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    A Closer Look Into Veritas Pharma Apr 21 2016 
    Dividend and Value Opportunities in the Large-Cap Pharmaceutical Space Apr 05 2016 
    Why the UK Is Headed For a Slowdown Mar 23 2016 
    Insiders Roundup: Theravance Biopharma, Western Gas, Upland Software Mar 18 2016 
    Brandes Makes a Variety of Reductions in 4th Quarter Feb 11 2016 
    10 Fund Managers Are Totally Wrong on GlaxoSmithKline Jan 26 2016 
    Stocks Bring High Dividend Yields to HOTCHKIS & WILEY Jan 14 2016 
    Jeff Auxier's Holdings Trading Below Peter Lynch Earnings Line Jan 04 2016 
    Cisco Systems, Microsoft and Intel Bring High Dividend Yields to First Eagle Investment Jan 04 2016 
    High Dividend Yield Ratios Are Hallmarks of Many Dodge & Cox Stakes Dec 21 2015 

    More From Other Websites
    GSK reformulates mouthwash into a gel to prevent infections in newborns Apr 29 2016
    GlaxoSmithKline Plc :GSK-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 29 2016
    Glaxo's Mouthwash-Inspired Gel for Babies Wins EU Agency Backing Apr 29 2016
    Reformulated GSK mouthwash endorsed as umbilical cord antiseptic Apr 29 2016
    GlaxoSmithKline (GSK) Q1 Earnings Lag, Revenues Up Y/Y Apr 28 2016
    Have income investors forgotten just how good GlaxoSmithKline plc and Vodafone Group plc really are? Apr 28 2016
    Advocates hold NYC protest over price of pneumonia vaccine Apr 27 2016
    Advocates hold NYC protest over price of pneumonia vaccine Apr 27 2016
    Glaxo Finally Finds Some Momentum Apr 27 2016
    GSK response to MSF vaccine report Apr 27 2016
    GlaxoSmithKline Shares Boosted by Strong First-Quarter Update Apr 27 2016
    [$$] GlaxoSmithKline Posts Healthy Profit With Earnings Rise Apr 27 2016
    GSK finds axing doctor payments needn't torpedo sales Apr 27 2016
    GSK finds axing doctor payments needn't torpedo sales Apr 27 2016
    GSK finds axing doctor payments needn't torpedo sales Apr 27 2016
    Strong sales growth and reduced costs boost GlaxoSmithKline plc’s results Apr 27 2016
    GSK sees rise in sales of vaccines, healthcare products Apr 27 2016
    GSK sees rise in sales of vaccines, healthcare products Apr 27 2016
    Glaxo CEO: Price Pressure Continues in United States Apr 27 2016
    GlaxoSmithKline rebound gathering pace, says outgoing CEO Apr 27 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)